Open interest on Hyperliquid's tokenised-equity and commodity markets crossed $4 billion for the first time last week. Grayscale has put the CME market-maker threshold at $5 billion.
Hyperliquid's HIP-3 markets passed $4 billion in open interest for the first time on 5 August, according to on-chain data tracked through the week. The milestone matters less as a round number than as a distance measurement: Grayscale's research desk has argued that $5 billion is the point at which the professional market-making firms that quote on CME and Cboe start bringing their books to a chain-native venue.
HIP-3 is the extension Hyperliquid shipped earlier this year to let permissioned deployers list perpetual contracts on assets that are not tokens. In practice, that means tokenised US equities, gold, oil, and a growing list of commodities, traded 24 hours a day against on-chain collateral. It sits alongside the exchange's original crypto perp book rather than replacing it, and until recently was a small fraction of the parent product.
HIP-3 open interest sat at roughly $790 million in January, cleared $3.2 billion at its June peak, and doubled again to $4 billion in six weeks. The pace has been steady rather than reflexive: no single asset listing accounts for the run, and the top of the book is diversified across equities and commodities rather than concentrated in a handful of blue-chip names. That is the profile a market-making desk wants before it commits capital.
Grayscale's $5 billion figure is not a regulatory line, but a commercial one. Below it, the depth on any single instrument is thin enough that a professional book has to eat wide spreads to hedge. Above it, the tokenised contract begins to look like a plausible venue for the delta hedge on a CME position, with the same underlying, a tighter fee schedule, and no clearing member overhead. The gap between $4 billion and $5 billion is not much; the composition of that last billion will determine whether the crossover comes with real institutional flow or another quarter of retail-driven growth.
The same week that HIP-3 cleared the threshold, the rest of Hyperliquid was going the other way. Total open interest across all perpetual markets slipped to $10.75 billion on 6 August from a July peak above $11 billion. Daily trading volume dropped roughly 17 per cent on the day to $2.98 billion. The HYPE token was down 2.74 per cent in the same session. Active perp traders, however, hit an all-time high of 263,666, which suggests the volume compression is a per-trader effect rather than an exodus.
That divergence, with more traders spread across smaller books and growing non-crypto exposure, reads as a maturation problem rather than a slowdown. Hyperliquid's crypto perp business has been the dominant on-chain derivatives venue since Q1 2026, taking about 70 per cent of on-chain perpetual futures volume and processing $218 billion in July alone. That is more than the combined total of the next seven perp DEXes. Growth from that base is arithmetically harder to come by, and the marginal user is likely trading with less leverage than the cohort that arrived in 2025.
HIP-3 is the escape valve for that ceiling. Every equity or commodity contract added to the book is a market where Hyperliquid competes with CME or Cboe on trading hours and cost, not with Binance or Bybit on token variety. It is a materially larger addressable market, and one where the incumbents have limited technical latitude to respond — a CME session close cannot be reopened by ticket, and the tokenised contract runs continuously.
The risk is that the tokenised-equity book runs into the same regulatory questions that killed several US retail attempts in the last cycle. Hyperliquid's approach, in which permissioned deployers take responsibility for the listing rather than a central exchange operator, is a workable answer for the moment, but it has not been tested by an SEC or CFTC action. A single enforcement letter to a US-facing deployer would compress the growth curve immediately, whatever the collateralisation looks like on-chain.
For now the numbers keep going the right way. Hyperliquid has already surpassed $1 billion in daily volume as a routine event and is running a business large enough that its next legs of growth have to come from adjacent markets rather than more of the same. HIP-3 is the bet it has made. The professional market-making community is a plausible customer if the book keeps compounding at this rate, and Grayscale's threshold puts a rough date on when the courtship begins.
